查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1850553

周邊血管器械市場按產品類型、技術類型、材料類型、適應症、患者類型和最終用戶分類－2025-2032年全球預測

Peripheral Vascular Devices Market by Product, Technology Type, Material Type, Indication, Patient Types, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，周邊血管器械市場規模將達到 237.2 億美元，複合年成長率為 6.19%。

主要市場統計數據
基準年 2024 146.6億美元
預計年份：2025年 155億美元
預測年份：2032年 237.2億美元
複合年成長率 (%) 6.19%

本文重點介紹臨床實務、設備創新和衛生系統管理的機會和挑戰。

周邊血管介入器械正處於人口老化、疾病負擔變化和手術技術快速創新交匯的階段。臨床醫生越來越依賴各種器械，從微創導管介入到開放式外科移植。手術方式的多樣化促使人們需要整合臨床路徑，以最佳化患者預後並控制成本。因此，醫院系統和門診手術中心正在重新審視器械配方、器械採用標準和庫存策略，以在常規血管介入治療中平衡療效和可重複性。

同時，不斷變化的監管法規正在重新定義證據閾值和上市後監測預期，促使製造商投資於更早期、更可靠的臨床數據，並採用考慮產品生命週期的迭代式設備設計。從支付方的角度來看，基於價值的報銷結構和手術環境的轉變，正在創造新的獎勵，促使他們優先選擇那些能夠顯著降低再入院率、手術併發症和縮短功能恢復時間的設備。所有這些因素共同作用，使得臨床領導者、設備開發人員和醫療系統採購者之間的跨領域合作至關重要，才能將創新轉化為可擴展的醫療服務改進。

展望未來，能夠協調臨床證據、生產靈活性和報銷資訊的公司將獲得策略優勢，從而滿足臨床醫生的偏好和醫療保健提供者的採購標準。

全面審視正在改變周邊血管護理臨床實踐、技術應用和競爭動態的變革性轉變。

周邊血管器材的臨床應用格局正經歷多重同步轉變，重塑其應用模式與競爭格局。微創技術正持續拓展應用範圍，惠及以往接受開放性手術的患者群，主要得益於導管設計、斑塊修復技術和支架材料的改進。術中影像和導航技術的進步也推動了這一趨勢，提高了手術精準度，並擴大了血管內治療的適應症範圍。隨著臨床醫生和醫療系統傾向於選擇創傷更小、能夠加快康復速度並減少住院次數的治療途徑，製造商在設計下一代解決方案時，必須優先考慮易用性、互通性和可靠的臨床療效。

同時，材料科學的進步使人們重新關注醫療器材的長期生物相容性和耐久性。某些器械材料轉向鎳鈦合金、鈷鉻合金、聚合物塗層和混合材料，反映出製造商致力於最佳化徑向強度、輸送性和內皮化特性。法律規範和支付方越來越重視安全訊號和實際應用效果，迫使醫療設備製造商將上市後證據的產生納入其產品策略。此外，隨著相關人員尋求提高前置作業時間和庫存的透明度並降低中斷風險，對供應鏈韌性和在地化生產的投資正成為策略重點。

總而言之，這些變革性的轉變凸顯了以證據為導向的商業化方法的重要性，這種方法將臨床效用與可擴展的生產和分銷模式相結合。

分析探討2025年美國關稅如何影響醫療設備製造商的供應鏈結構、籌資策略和商業營運。

2025年實施的關稅調整迫使設備製造商和經銷商重新評估其全球採購佈局和製造外包夥伴關係。雖然關稅針對的是特定原料和成品，但其更廣泛的影響正在加速對近岸外包機會、雙重採購條款以及關鍵零件生產的垂直整合的評估。製造商擴大採用總到岸成本模型，該模型考慮了關稅和運費波動以及庫存持有成本，以幫助他們做出供應商選擇和資本投資決策。因此，設備開發人員優先考慮那些能夠提供地理多樣性、品質穩定性和根據需求波動靈活調整生產規模的供應商關係。

監管註冊時限和進口合規要求也在影響企業的市場准入策略。依賴跨國供應鏈的企業必須應對額外的行政複雜性以及可能延長的前置作業時間，尤其對於包含複雜多組件的設備而言更是如此。因此，採購團隊正在修訂合約條款，增加海關緊急條款，並加強與海關和貿易合規專業人員的合作，以維護利潤空間。對於規模較小的創新企業而言，海關環境使得與已合規且擁有多元化供應鏈的成熟製造商達成許可協議和戰略合作夥伴關係更具吸引力。

總而言之，2025 年的關稅狀況​​為將重點轉移到韌性和成本透明度上提供了一個切實的機會，鼓勵對供應鏈可視性、替代採購和更具抗貿易政策波動能力的製造策略進行投資。

將產品類別、手術技術、材料、臨床適應症、患者群體和終端用戶環境等方面的細分洞察進行詳細整合，以指導有針對性的商業化策略。

產品層面的異質性決定了臨床和採購相關人員如何評估周邊血管產品。市場涵蓋球囊擴張裝置、各種導管類型、移植物、導管導引線、下腔靜脈濾器、導引器、斑塊修飾裝置、支架和血管閉合系統。在導管方面，長導管、中線導管和短導管之間的差異會影響手術方案的選擇、庫存管理和臨床醫生培訓的重點。移植物的選擇反映了材料和生物學的考慮，生物移植物、發泡聚四氟乙烯移植物和聚酯移植物各自具有獨特的操作特性和長期性能權衡。支架技術進一步分為球囊擴張式和自擴張式，臨床醫師根據病變形態、血管大小和輸送需求進行選擇。

技術類型細分市場主要區分微創手術和開放手術。斑塊的可輸送性、影像相容性和斑塊修飾輔助工具是優先考慮的因素，尤其對於血管成形術和支架植入術等微創治療方法而言更是如此。相反，搭橋手術和置入術等開放性手術則需要可靠的移植物選擇、灌注方面的考量以及專用器械。金屬和非金屬器械的材料差異決定了器械的選擇，主要體現在徑向強度、抗疲勞性和生物相容性等方面。金屬器械的亞型包括鈷鉻合金、鎳鈦合金和不銹鋼，而非金屬器械則包括聚合物和矽基材料，並採用不斷發展的塗層技術。

依臨床適應症和患者類型進行細分也會影響商業性優先事項。適應症涵蓋功能性周邊血管疾病，如慢性靜脈功能不全、雷諾氏症和靜脈曲張，以及阻塞性疾病，如動脈粥狀硬化、血栓閉塞性脈管炎、頸動脈疾病、深層靜脈栓塞症和淋巴水腫。患者類別包括按急性或慢性疾病區分的成人和老年人群，以及患有後天性或先天性疾病的兒童群體。終端使用者環境，例如門診手術中心、門診診所和醫院，各自有不同的採購週期、法律規範和對臨床醫生能力的要求。整合這些細分視角，能夠幫助企業將產品設計、臨床證據產生和上市模式與目標臨床管道和醫療保健採購方的需求相匹配。

深入了解全球主要區域的需求促進因素、法規環境、基礎設施能力和戰略重點，為市場進入和擴張計劃提供資訊。

區域動態顯著影響周邊血管器材在醫療機構的應用、報銷和部署。在美洲，成熟的醫療體系、完善的報銷管道和較高的手術量支持新型微創器材的快速普及，而多樣化的支付模式和醫院整合趨勢則要求採用細緻的合約簽訂方式。相較之下，歐洲、中東和非洲的監管環境差異顯著，基礎設施也不斷變化。歐洲市場通常強調嚴格的臨床證據和集中採購框架，而中東和非洲市場則可能優先考慮與當地臨床專長和供應鏈限制相符的技術。這些差異要求制定適應性強的打入市場策略和有針對性的證據包裝，以滿足各區域特定的監管和臨床需求。

亞太地區的醫療基礎設施和發展軌跡呈現出顯著的異質性。重點市場對三級醫療中心的快速投資和不斷提升的治療能力，推動了對先進支架系統和可擴展導管解決方案的需求。然而，不同的監管管道、在地化生產獎勵以及成本敏感性，要求製造商精心製定定價和在地化策略。在各個地區，醫療系統的共同優先事項——縮短住院時間、提高手術效率和降低併發症率——是器械開發商可以透過實證產品聲明和客製化臨床支援計畫來解決的普遍問題。最終，結合嚴謹的臨床數據、監管專業知識和營運夥伴關係的差異化區域策略，全部區域實現永續應用至關重要。

主要企業，著重介紹競爭定位、關鍵創新領域、夥伴關係動態以及設備製造商和服務供應商的策略要務。

周邊血管器械領域的主要企業透過不斷改進器械和平台層面的創新來提升手術效率和改善患者的長期預後，從而實現差異化競爭。一些企業優先開發模組化系統，以提高與現有導管和影像平台的兼容性；而另一些企業則專注於材料科學的突破，以最佳化輸送性能血管再阻塞。隨著器械製造商尋求提供能夠簡化臨床醫生工作流程並支持術中決策的整合式手術解決方案，他們與影像處理或數位醫療服務提供者之間的策略聯盟正變得越來越普遍。此外，與契約製造製造商或本地生產基地合作有助於確保供應鏈的靈活性，並降低貿易中斷帶來的風險。

競爭優勢也取決於企業如何看待臨床證據和健保報銷支援。投資於務實的臨床試驗設計、註冊合作以及衛生經濟學文件的企業，更有能力向支付者和機構買家證明其價值。對於創新者和規模較小的新參與企業，許可協議、聯合開發聯盟以及與醫療系統的定向合作，既能幫助企業擴大規模，又能共用研發風險。在這種競爭環境下，成功的企業既要兼顧短期商業性執行，又要對產品系列進行長期投資，以因應臨床實務和監管環境的變化。

為產業領導者提供切實可行的建議，以優先考慮永續成長的投資、協調臨床證據策略並最佳化供應鏈韌性。

首先，我們優先開展臨床證據項目，這些項目既關注短期治療效果，也關注以患者為中心的長期終點。我們透過設計可操作的研究和註冊登記，並將其與常規診療路徑無縫銜接，從而加快臨床醫生接受新療法的步伐，並支持與支付方的互動。其次，我們在開發新設備時注重模組化和互通性，以減少臨床醫生培訓的阻力，並提高其與現有手術室的整合率。第三，我們透過提高供應鏈透明度和實現採購多元化，最大限度地降低關稅和物流瓶頸造成的成本波動風險。透過將部分零件的生產外包到海外，並與供應商建立冗餘關係，我們能夠在保持生產連續性的同時，最佳化落地成本。

第四，根據當地監管和報銷政策的細微差別調整打入市場策略，確保區域性的證據包裝和定價框架能夠反映臨床優先事項和支付方的閾值。第五，制定臨床醫生的價值提案，其中不僅包括設備性能，還包括培訓、手術支援和結果追蹤功能。最後，與影像和數位醫療服務提供者建立策略夥伴關係，以產生能夠增強術中決策、支援產品應用和報銷的真實世界證據。透過將主導商業化與營運韌性和合作夥伴關係相結合，行業領導者可以應對複雜的市場環境，並實現持續的臨床和商業性影響。

透明的調查方法解釋了證據來源、分析框架和檢驗步驟，這些都為報告的見解和建議提供了支持。

調查方法結合了對臨床、監管和商業相關人員的訪談，以及對同行評審文獻、監管文件和公開臨床註冊資料的廣泛二次分析。一手研究包括與介入性心臟病專家、血管外科醫生、採購負責人以及器械和契約製造的高階主管進行結構化對話，以了解實際營運中的限制和策略重點。二次研究則整合了器械附加檔、臨床試驗註冊資料、監管指導文件和已發表的療效研究，以檢驗性能特徵和手術趨勢。

分析框架整合了跨裝置類別、技術類型、材料配置、臨床適應症、患者人口統計特徵和醫療環境的細分分析。這些框架有助於進行橫斷面比較，並識別影響產品採納的價值促進因素。檢驗步驟包括將主要訪談結果與次要證據進行交叉比對、對主題結論進行敏感性檢驗，以及與臨床專家進行同行評審，以確保臨床結論的準確性和有效性。這種嚴謹的方法確保了建議得到多方面證據的支持，並反映了影響臨床和商業性受眾決策的實際考慮。

簡潔扼要的結論，綜合闡述了對相關人員的影響，並為不斷發展的周邊血管器械生態系統制定了策略重點。

周邊血管介入器材領域正經歷快速的手術技術革新、材料創新和不斷變化的經濟獎勵，這要求製造商和醫療系統採取靈活且以實證醫學為導向的策略。臨床實務正朝著微創方向發展，許多適應症的治療也更加重視器械在簡化的手術流程中保持穩定的效能。同時，監管機構和付款方的期望也促使人們更加重視上市後監測和基於結果的證據，凸顯了長期資料收集和價值論證的重要性。

為了取得成功，相關人員必須將設備創新與可操作的臨床證據和穩健的營運模式結合。這需要投資於可互通的技術，制定針對特定地區的市場推廣計劃，並加強能夠抵禦政策和物流衝擊的供應鏈。最終，能夠將臨床差異化與臨床醫生、患者和支付方的明確價值聯繫起來的公司，將在複雜多變的市場環境中佔據更有利的地位，並獲得市場認可。隨著產業的發展，這些策略重點應指南近期戰術性決策和長期投資組合。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 增加藥物塗層球囊在降低周邊動脈疾病血管再阻塞的應用
  • 將人工智慧整合到成像系統中以增強周邊血管介入治療規劃
  • 增加生物可吸收支架的使用，以最大限度地減少長期周邊血管併發症
  • 微導管技術的進步改善了在複雜周邊血管系統中的導航。
  • 對下肢床邊評估的可攜式血管超音波設備的需求不斷成長
  • 用於精確清除周邊動脈斑塊的動脈粥狀硬化切除裝置的創新
  • 擴大遠端醫療遠距監測解決方案在術後周邊血管患者的應用

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊血管器械市場（依產品分類）

  • 氣球充氣裝置
  • 導管
    • 長周邊靜脈導管
    • 中線導管
    • 短周邊靜脈導管
  • 移植
    • 生物移植
    • ePTFE 接枝
    • 聚酯接骨
  • 導管導引線
  • 下腔靜脈濾器
  • 介紹人
  • 斑塊修飾裝置
  • 支架
    • 球囊擴張支架
    • 自膨式支架
  • 血管閉合裝置

9. 依技術類型分類的周邊血管器材市場

  • 微創手術
    • 血管成形術
    • 支架置入術
  • 開放性手術
    • 心臟繞道手術
    • 切除術

第10章 依材料類型的周邊血管器械市場

  • 金屬裝置
    • 鈷鉻
    • 鎳鈦諾
    • 防鏽的
  • 非金屬裝置
    • 聚合物
    • 矽

第11章 周邊血管器械市場（依適應症分類）

  • 功能性周邊血管疾病
    • 慢性靜脈功能不全
    • 雷諾氏症
    • 靜脈曲張
  • 阻塞性周邊血管疾病
    • 動脈硬化
    • 血栓閉塞性脈管炎
    • 頸動脈疾病
    • 深層靜脈栓塞症
    • 淋巴水腫

12. 依患者類型分類的周邊血管器械市場

  • 成年人和老年人
    • 急性疾病
    • 慢性病
  • 孩子們
    • 後天疾病
    • 先天性疾病

第13章 周邊血管器械市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院

14. 周邊血管器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 周邊血管器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國周邊血管器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • AngioDynamics, Inc.
    • Argon Medical Devices, Inc.
    • ASAHI INTECC CO., LTD
    • B. Braun SE
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Cook Group Incorporated
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE HealthCare
    • Kimal PLC
    • Koninklijke Philips NV
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Nipro Corporation
    • Penumbra, Inc.
    • Sahajanand Medical Technologies Limited
    • Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
    • Siemens Healthineers AG
    • Summa Therapeutics, LLC
    • Teleflex Incorporated
    • Terumo Corporation
    • WL Gore & Associates, Inc.
Product Code: MRR-374DB5A063C3

The Peripheral Vascular Devices Market is projected to grow by USD 23.72 billion at a CAGR of 6.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 14.66 billion
Estimated Year [2025] USD 15.50 billion
Forecast Year [2032] USD 23.72 billion
CAGR (%) 6.19%

A focused introduction that frames opportunities and challenges across clinical practice, device innovation, and health systems management

The peripheral vascular devices landscape sits at the intersection of aging demographics, shifting disease burden, and accelerating procedural innovation. Clinicians increasingly rely on a spectrum of devices that span minimally invasive catheter-based therapies to open surgical grafts, and this procedural diversification has elevated the need for integrated clinical pathways that optimize patient outcomes while controlling costs. As a result, hospital systems and ambulatory surgical centers are re-evaluating formularies, device adoption criteria, and inventory strategies to balance efficacy with reproducibility in routine vascular interventions.

Concurrent regulatory evolution is redefining evidence thresholds and post-market surveillance expectations, prompting manufacturers to invest earlier in robust clinical data and to design iterative devices with lifecycle considerations. From a payer perspective, value-based reimbursement constructs and shifting procedure settings are creating new incentives to prioritize devices that demonstrably reduce readmissions, procedural complications, and time to functional recovery. Taken together, these drivers place a premium on cross-disciplinary collaboration among clinical leaders, device developers, and health system purchasers to translate innovation into scalable care delivery improvements.

Looking ahead, companies that harmonize clinical evidence, manufacturing agility, and reimbursement intelligence will capture the strategic advantage required to meet both clinician preferences and institutional procurement standards.

A comprehensive view of transformative shifts altering clinical practice, technology adoption, and competitive dynamics across peripheral vascular care

The clinical environment for peripheral vascular devices is undergoing several concurrent shifts that are reshaping adoption patterns and competitive positioning. Minimally invasive techniques continue to expand into patient cohorts previously treated with open surgery, driven by refinements in catheter design, plaque modification technologies, and stent materials. This trend has been enabled by improvements in intraprocedural imaging and navigation, which increase procedural precision and broaden the indications suitable for endovascular approaches. As clinicians and health systems favor less invasive pathways that shorten recovery and reduce hospitalization, manufacturers must emphasize ease-of-use, cross-compatibility, and robust clinical outcomes when designing next-generation solutions.

In parallel, material science advances are prompting renewed attention to long-term biocompatibility and device durability. The shift toward nitinol and cobalt chromium alloys in select classes, along with polymer-based coatings and hybrid materials, reflects a drive to optimize radial strength, deliverability, and endothelialization profiles. Regulatory frameworks and payers are increasingly scrutinizing safety signals and real-world performance, which compels device makers to integrate post-market evidence generation into product strategies. Furthermore, supply chain resilience and localized manufacturing investments are becoming strategic priorities as stakeholders seek to mitigate disruption risks while improving lead times and inventory visibility.

Taken together, these transformative shifts underscore the importance of an evidence-centered commercialization approach that aligns clinical utility with scalable manufacturing and distribution models.

An analytical exploration of how the United States tariffs implemented in 2025 are influencing supply chain configurations, sourcing strategies, and commercial operations for device manufacturers

The tariff adjustments introduced in the United States in 2025 have prompted device manufacturers and distributors to reassess global sourcing footprints and contract manufacturing partnerships. While tariffs target specific input categories and finished goods, the broader consequence has been accelerated evaluation of nearshoring opportunities, dual-sourcing provisions, and vertical integration of critical component production. Manufacturers are increasingly modeling total landed costs that account for tariffs, freight volatility, and inventory carrying expenses to inform supplier selection and capital investment decisions. As a result, device developers are prioritizing supplier relationships that offer geographic diversification, quality consistency, and built-in flexibility to scale production in response to demand fluctuations.

Regulatory registration timelines and import compliance considerations are also shaping how firms approach market entry. Companies that rely on multinational supply chains must negotiate additional administrative complexity and potential lead-time extension, particularly for devices with complex multi-component assemblies. Consequently, procurement teams are revisiting contractual terms, adding tariff contingency clauses, and intensifying collaboration with customs and trade compliance experts to preserve margin integrity. For smaller innovators, the tariff environment has increased the comparative attractiveness of licensing agreements or strategic alliances with established manufacturers that already operate compliant, diversified supply chains.

In sum, the 2025 tariff landscape has catalyzed a pragmatic pivot toward resilience and cost transparency, incentivizing investments in supply chain visibility, alternative sourcing, and manufacturing strategies that better absorb trade policy volatility.

A detailed synthesis of segmentation insights across product classes, procedural technologies, materials, clinical indications, patient cohorts, and end-user settings to inform targeted commercialization strategies

Product-level heterogeneity defines how clinical and procurement stakeholders evaluate peripheral vascular offerings. The market spans balloon inflation devices, a variety of catheter types, grafts, guidewires, inferior vena cava filters, introducers, plaque modification devices, stents, and vascular closure systems. Within catheters, distinctions among long peripheral intravenous catheters, midline catheters, and short peripheral intravenous catheters influence procedural selection, inventory management, and clinician training priorities. Graft choices reflect material and biological considerations, with biological grafts, expanded polytetrafluoroethylene constructions, and polyester grafts each presenting unique handling characteristics and long-term performance trade-offs. Stent technologies further bifurcate into balloon-expandable and self-expanding designs, which clinicians select based on lesion morphology, vessel sizing, and deliverability requirements.

Technology type segmentation contrasts minimally invasive surgeries with open surgical approaches. Minimally invasive pathways, particularly angioplasty and stenting, prioritize device deliverability, imaging compatibility, and adjunctive tools for plaque modification. Conversely, open surgical interventions such as bypass procedures and endarterectomy necessitate robust graft options, perfusion considerations, and specialized instrumentation. Material differentiation between metal devices and non-metal devices drives choices around radial strength, fatigue resistance, and biocompatibility; metal device subtypes include cobalt chromium, nitinol, and stainless steel, while non-metal alternatives encompass polymers and silicone-based solutions with evolving coating technologies.

Clinical indication and patient-type segmentation also shape commercial priorities. Indications span functional peripheral vascular disease-encompassing chronic venous insufficiency, Raynaud's disease, and varicose veins-and occlusive pathology including atherosclerosis, Buerger's disease, carotid artery disease, deep vein thrombosis, and lymphedema. Patient categories include adult and geriatric cohorts differentiated by acute versus chronic conditions, as well as pediatric populations with acquired or congenital conditions. End-user settings such as ambulatory surgical centers, outpatient clinics, and hospitals each impose different procurement cycles, regulatory oversight, and clinician proficiency expectations. Integrating these segmentation lenses enables companies to align product design, clinical evidence generation, and go-to-market models with the needs of targeted clinical pathways and institutional purchasers

Regional insights that elucidate demand drivers, regulatory environments, infrastructure capacity, and strategic priorities across major global geographies to inform market entry and expansion plans

Regional dynamics materially influence how peripheral vascular devices are adopted, reimbursed, and diffused across care settings. In the Americas, mature healthcare systems, established reimbursement pathways, and high procedure volumes support rapid adoption of novel minimally invasive devices, while divergent payer models and hospital consolidation trends require nuanced contracting approaches. In contrast, Europe, the Middle East and Africa present a mosaic of regulatory heterogeneity and variable infrastructure. European markets often emphasize rigorous clinical evidence and centralized procurement frameworks, whereas Middle Eastern and African markets may prioritize technology that aligns with local clinical expertise and supply chain constraints. These differences necessitate adaptive market access strategies and targeted evidence packages to meet region-specific regulatory and clinical expectations.

The Asia-Pacific region exhibits pronounced heterogeneity in healthcare infrastructure and growth trajectories. Rapid investments in tertiary care centers and increasing procedural capacity in key markets are driving demand for both advanced stent systems and scalable catheter solutions. However, divergent regulatory pathways, local manufacturing incentives, and cost sensitivity require manufacturers to calibrate pricing and localization strategies carefully. Across all regions, health system priorities such as reducing hospital length of stay, improving procedural throughput, and minimizing complication rates serve as universal levers that device developers can address through evidence-based product claims and tailored clinical support programs. Ultimately, a differentiated regional approach that combines rigorous clinical data, regulatory expertise, and operational partnerships will be essential to achieving sustainable adoption across these geographies

Key company insights highlighting competitive positioning, innovation focus areas, partnership dynamics, and strategic imperatives for device manufacturers and service providers

Leading companies in the peripheral vascular device domain are differentiating through a combination of incremental device improvements and platform-level innovations that address procedural efficiency and long-term patient outcomes. Some firms are prioritizing modular systems that enhance cross-compatibility with existing catheter and imaging platforms, whereas others concentrate on material science breakthroughs to optimize deliverability and reduce restenosis. Strategic alliances between device manufacturers and imaging or digital health providers are becoming more common as companies seek to deliver integrated procedural solutions that streamline clinician workflows and support intraoperative decision-making. In addition, partnerships with contract manufacturers and localized production hubs help secure supply chain flexibility and reduce exposure to trade-related disruptions.

Competitive differentiation also hinges on how companies approach clinical evidence and reimbursement support. Firms that invest in pragmatic trial designs, registry partnerships, and health economics dossiers are better positioned to demonstrate value to payers and institutional buyers. For innovators and smaller entrants, licensing agreements, co-development alliances, and targeted collaborations with health systems provide pathways to scale while sharing development risk. Across the competitive landscape, successful players balance near-term commercial execution with longer-term investments in product portfolios that anticipate shifts in clinical practice and regulatory expectations

Actionable recommendations that equip industry leaders to prioritize investments, align clinical evidence strategies, and optimize supply chain resilience for sustained growth

First, prioritize clinical evidence programs that address both short-term procedural outcomes and longer-term patient-centric endpoints. Designing pragmatic studies and registries that integrate seamlessly with routine care pathways will accelerate clinician acceptance and support payer conversations. Second, invest in modularity and interoperability when developing new devices to reduce clinician training friction and increase the likelihood of integration into existing procedural suites. Third, strengthen supply chain visibility and diversify sourcing to minimize exposure to tariff-driven cost fluctuations and logistical bottlenecks. Nearshoring certain components and cultivating redundant supplier relationships can preserve production continuity while optimizing landed costs.

Fourth, tailor market access strategies to regional regulatory and reimbursement nuances, ensuring that localized evidence packages and pricing frameworks reflect clinical priorities and payer thresholds. Fifth, develop clinician-facing value propositions that extend beyond device performance to include training, procedural support, and outcomes-tracking capabilities. Finally, pursue strategic partnerships with imaging and digital health providers to enhance intraoperative decision-making and to generate real-world evidence that supports adoption and reimbursement. By combining evidence-led commercialization with operational resilience and collaborative partnerships, industry leaders can better navigate market complexity and drive sustained clinical and commercial impact

A transparent research methodology explaining the evidence sources, analytic frameworks, and validation steps that underpin the insights and recommendations in the report

The research methodology combines primary interviews with clinical, regulatory, and commercial stakeholders and extensive secondary analysis of peer-reviewed literature, regulatory filings, and publicly available clinical registries. Primary engagements include structured conversations with interventional cardiologists, vascular surgeons, procurement leaders, and senior executives from device firms and contract manufacturers to capture real-world operational constraints and strategic priorities. Secondary research synthesizes device labeling, clinical trial registries, regulatory guidance documents, and published outcomes studies to triangulate performance characteristics and procedural trends.

Analytic frameworks incorporate segmentation analysis across device class, technology type, material composition, clinical indication, patient demographics, and care setting. These frameworks drive cross-sectional comparisons and enable identification of value drivers that influence adoption. Validation steps include cross-referencing primary interview findings with secondary evidence, performing sensitivity checks on thematic conclusions, and conducting peer reviews with clinical experts to ensure the accuracy and relevance of clinical assertions. This rigorous approach ensures that recommendations are grounded in multiple evidence streams and reflect the practical considerations that shape decision-making across clinical and commercial audiences

A concise conclusion that synthesizes implications for stakeholders and frames strategic priorities for the evolving peripheral vascular device ecosystem

The peripheral vascular device environment is characterized by rapid procedural evolution, material innovation, and shifting economic incentives that collectively demand agile, evidence-centered strategies from manufacturers and health systems alike. Clinical pathways are trending toward less invasive approaches in many indications, which places a premium on devices that deliver consistent performance with streamlined procedural workflows. Simultaneously, regulatory and payer expectations are driving deeper commitments to post-market surveillance and outcomes-based evidence, reinforcing the importance of long-term data collection and value demonstration.

To succeed, stakeholders must harmonize device innovation with pragmatic clinical evidence and resilient operational models. This entails investing in interoperable technologies, targeting regionally tailored market access plans, and fortifying supply chains to withstand policy and logistical shocks. Ultimately, companies that can translate clinical differentiation into clear value for clinicians, patients, and payers will be best positioned to capture adoption in a complex and rapidly changing landscape. These strategic priorities should guide near-term tactical decisions and longer-term portfolio investments as the industry moves forward

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of drug-coated balloons to reduce restenosis in peripheral artery disease
  • 5.2. Integration of artificial intelligence in imaging systems to enhance peripheral vascular intervention planning
  • 5.3. Rising use of bioresorbable scaffolds to minimize long-term complications in peripheral vessels
  • 5.4. Advancements in microcatheter technology to improve navigation through complex peripheral vasculature
  • 5.5. Growing demand for portable vascular ultrasound devices for point-of-care lower limb assessments
  • 5.6. Innovations in atherectomy devices for precise removal of peripheral arterial plaque
  • 5.7. Expansion of telehealth remote monitoring solutions for post-procedural peripheral vascular patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Devices Market, by Product

  • 8.1. Balloon Inflation Devices
  • 8.2. Catheters
    • 8.2.1. Long Peripheral Intravenous Catheters
    • 8.2.2. Midline Catheters
    • 8.2.3. Short Peripheral Intravenous Catheter
  • 8.3. Grafts
    • 8.3.1. Biological Grafts
    • 8.3.2. ePTFE Grafts
    • 8.3.3. Polyester Grafts
  • 8.4. Guidewires
  • 8.5. Inferior Vena Cava Filters
  • 8.6. Introducers
  • 8.7. Plaque Modification Devices
  • 8.8. Stents
    • 8.8.1. Balloon-Expandable Stents
    • 8.8.2. Self-Expanding Stents
  • 8.9. Vascular Closure Devices

9. Peripheral Vascular Devices Market, by Technology Type

  • 9.1. Minimally Invasive Surgeries
    • 9.1.1. Angioplasty
    • 9.1.2. Stenting
  • 9.2. Open Surgery
    • 9.2.1. Bypass Surgery
    • 9.2.2. Endarterectomy

10. Peripheral Vascular Devices Market, by Material Type

  • 10.1. Metal Devices
    • 10.1.1. Cobalt Chromium
    • 10.1.2. Nitinol
    • 10.1.3. Stainless Steel
  • 10.2. Non-Metal Devices
    • 10.2.1. Polymer
    • 10.2.2. Silicone

11. Peripheral Vascular Devices Market, by Indication

  • 11.1. Functional Peripheral Vascular Disease
    • 11.1.1. Chronic Venous Insufficiency
    • 11.1.2. Raynaud's Disease
    • 11.1.3. Varicose Veins
  • 11.2. Occlusive Peripheral Vascular Disease
    • 11.2.1. Atherosclerosis
    • 11.2.2. Buerger's Disease
    • 11.2.3. Carotid Artery Disease
    • 11.2.4. Deep Vein Thrombosis
    • 11.2.5. Lymphedema

12. Peripheral Vascular Devices Market, by Patient Types

  • 12.1. Adult & Geriatric
    • 12.1.1. Acute Conditions
    • 12.1.2. Chronic Conditions
  • 12.2. Pediatric
    • 12.2.1. Acquired Conditions
    • 12.2.2. Congenital Conditions

13. Peripheral Vascular Devices Market, by End-User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Peripheral Vascular Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Peripheral Vascular Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Peripheral Vascular Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. AngioDynamics, Inc.
    • 17.3.3. Argon Medical Devices, Inc.
    • 17.3.4. ASAHI INTECC CO., LTD
    • 17.3.5. B. Braun SE
    • 17.3.6. Baxter International Inc.
    • 17.3.7. Becton, Dickinson and Company
    • 17.3.8. BIOTRONIK SE & Co. KG
    • 17.3.9. Boston Scientific Corporation
    • 17.3.10. Cardinal Health, Inc.
    • 17.3.11. Cook Group Incorporated
    • 17.3.12. Esaote S.p.A.
    • 17.3.13. FUJIFILM Holdings Corporation
    • 17.3.14. GE HealthCare
    • 17.3.15. Kimal PLC
    • 17.3.16. Koninklijke Philips N.V.
    • 17.3.17. Lepu Medical Technology (Beijing) Co., Ltd.
    • 17.3.18. Medtronic PLC
    • 17.3.19. Merit Medical Systems, Inc.
    • 17.3.20. Nipro Corporation
    • 17.3.21. Penumbra, Inc.
    • 17.3.22. Sahajanand Medical Technologies Limited
    • 17.3.23. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
    • 17.3.24. Siemens Healthineers AG
    • 17.3.25. Summa Therapeutics, LLC
    • 17.3.26. Teleflex Incorporated
    • 17.3.27. Terumo Corporation
    • 17.3.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL PERIPHERAL VASCU